publication . Article . 2018

Metastasis Targeted Therapies in Renal Cell Cancer

K. Fehmi Narter; Bora Özveren;
Open Access English
  • Published: 01 Apr 2018 Journal: Üroonkoloji Bülteni (issn: 2147-2270, Copyright policy)
  • Publisher: Galenos Yayinevi
Abstract
Metastatic renal cell cancer is a malignant disease and its treatment has been not been described clearly yet. These patients are generally symptomatic and resistant to current treatment modalities. Radiotherapy, chemotherapy, and hormonal therapy are not curative in many of these patients. A multimodal approach consisting of cytoreductive nephrectomy, systemic therapy (immunotherapy or targeted molecules), and metastasectomy has been shown to be hopeful in prolonging the survival and improving the quality of life in some of these patients. Patients with oligometastatic disease and good performance status have better results following this multimodal approach. C...
Subjects
free text keywords: Cytoreductive nephrectomy, immunotherapy, metastasectomy, metastatic renal cancer, targeted molecular therapy, Medicine, R, Internal medicine, RC31-1245, Specialties of internal medicine, RC581-951, Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cell cancer, Oncology, medicine.medical_specialty, business.industry, business, Urology, Metastasis, medicine.disease
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2018

Metastasis Targeted Therapies in Renal Cell Cancer

K. Fehmi Narter; Bora Özveren;